- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
159 Clinical Trials near Gig Harbor, WA
Power is an online platform that helps thousands of patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerImatinib + Chemotherapy for Acute Lymphoblastic Leukemia
Trial Details
Key Eligibility Criteria
475 Participants Needed
Chemotherapy + Immunotherapy for Recurrent Ovarian Cancer
Trial Details
Key Eligibility Criteria
444 Participants Needed
Chemotherapy +/− Temsirolimus for Muscle Cancer
Trial Details
Key Eligibility Criteria
325 Participants Needed
Trial Details
Key Eligibility Criteria
280 Participants Needed
Platinum Chemotherapy for Triple-Negative Breast Cancer
Trial Details
Key Eligibility Criteria
415 Participants Needed
Immunotherapy + Targeted Therapy for Melanoma
Trial Details
Key Eligibility Criteria
300 Participants Needed
Risk Factor-Guided Therapy for Neuroblastoma
Trial Details
Key Eligibility Criteria
621 Participants Needed
Sacituzumab Tirumotecan for Breast Cancer
Trial Details
Key Eligibility Criteria
2400 Participants Needed
LP352 for Epilepsy
Trial Details
Key Eligibility Criteria
324 Participants Needed
Risankizumab for Ulcerative Colitis
Trial Details
Key Eligibility Criteria
530 Participants Needed
Ofatumumab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
180 Participants Needed
LP352 for Epilepsy
Trial Details
Key Eligibility Criteria
320 Participants Needed
Rilvegostomig + Pembrolizumab + Chemotherapy for Lung Cancer
Trial Details
Key Eligibility Criteria
880 Participants Needed
Testosterone Replacement for Hypogonadism
Trial Details
Key Eligibility Criteria
100 Participants Needed
LP352 for Dravet Syndrome
Trial Details
Key Eligibility Criteria
160 Participants Needed
Tulisokibart for Crohn's Disease
Trial Details
Key Eligibility Criteria
1380 Participants Needed
Trial Details
Key Eligibility Criteria
878 Participants Needed
Etavopivat for Sickle Cell Disease
Trial Details
Key Eligibility Criteria
408 Participants Needed
Etavopivat for Sickle Cell Anemia
Trial Details
Key Eligibility Criteria
325 Participants Needed
HLX22 + Trastuzumab + Chemotherapy for Gastric Cancer
Trial Details
Key Eligibility Criteria
550 Participants Needed
Why Other Patients Applied
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
Elacestrant for Breast Cancer
Trial Details
Key Eligibility Criteria
4220 Participants Needed
Navtemadlin + Ruxolitinib for Myelofibrosis
Trial Details
Key Eligibility Criteria
600 Participants Needed
Tulisokibart for Crohn's Disease
Trial Details
Key Eligibility Criteria
1200 Participants Needed
Venetoclax + Obinutuzumab/Acalabrutinib for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
120 Participants Needed
sac-TMT + Pembrolizumab for Breast Cancer
Trial Details
Key Eligibility Criteria
1530 Participants Needed
Retatrutide for Obesity
Trial Details
Key Eligibility Criteria
10000 Participants Needed
Saruparib + Camizestrant for Breast Cancer
Trial Details
Key Eligibility Criteria
500 Participants Needed
Dato-DXd + Rilvegostomig for Non-Small Cell Lung Cancer
Trial Details
Key Eligibility Criteria
675 Participants Needed
Armour Thyroid vs Synthetic T4 for Hypothyroidism
Trial Details
Key Eligibility Criteria
2800 Participants Needed
Bictegravir + Lenacapavir for HIV
Trial Details
Key Eligibility Criteria
577 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do clinical trials in Gig Harbor, WA pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do clinical trials in Gig Harbor, WA work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across trials in Gig Harbor, WA 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Gig Harbor, WA is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Gig Harbor, WA several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a medical study in Gig Harbor, WA?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest clinical trials in Gig Harbor, WA?
Most recently, we added Sacituzumab Tirumotecan for Breast Cancer, Risankizumab for Ulcerative Colitis and Trophic Feeding for Sepsis Prevention to the Power online platform.